scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
3.390
+0.080 (2.42%)
At close: Dec 20, 2024, 4:00 PM
3.410
+0.020 (0.59%)
After-hours: Dec 20, 2024, 4:10 PM EST

scPharmaceuticals Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for scPharmaceuticals stock have an average target of 15, with a low estimate of 12 and a high estimate of 18. The average target predicts an increase of 342.48% from the current stock price of 3.39.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $12 $15 $18 $18
Change +253.98% +342.48% +430.97% +430.97%
* Price targets were last updated on Nov 14, 2024.

Analyst Ratings

The average analyst rating for SCPH stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 222222
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong Buy Reiterates $18 +430.97% Nov 14, 2024
Craig-Hallum
Craig-Hallum
Strong Buy
Maintains
$16$12
Strong Buy Maintains $16$12 +253.98% Nov 14, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong Buy Reiterates $18 +430.97% Aug 19, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong Buy Reiterates $18 +430.97% May 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong Buy Reiterates $18 +430.97% Mar 14, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
37.26M
from 13.59M
Increased by 174.12%
Revenue Next Year
86.97M
from 37.26M
Increased by 133.41%
EPS This Year
-1.59
from -1.42
EPS Next Year
-0.91
from -1.59
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
----13.59M37.26M86.97M172.93M
Revenue Growth
-----174.12%133.41%98.83%
EPS
-1.77-1.31-1.02-1.30-1.42-1.59-0.910.48
EPS Growth
--------
Forward PE
-------7.01
No. Analysts -----887
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 39.3M 101.2M 213.9M
Avg 37.3M 87.0M 172.9M
Low 35.2M 72.5M 115.6M

Revenue Growth

Revenue Growth 202420252026202720282029
High
188.9%
171.7%
145.9%
Avg
174.1%
133.4%
98.8%
Low
158.8%
94.6%
32.9%

EPS Forecast

EPS 202420252026202720282029
High -1.35 -0.44 1.27
Avg -1.59 -0.91 0.48
Low -1.98 -1.27 0.01

EPS Growth

EPS Growth 202420252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.